Is glucose uptake (SUV) in non-small-cell lung cancer an independent prognostic marker?

被引：0
|
作者：
Schmuecking, M [1 ]
Baum, RP [1 ]
Liesenfeld, S [1 ]
Presselt, N [1 ]
Bonnet, R [1 ]
Leonhardi, J [1 ]
Niesen, A [1 ]
Schneider, CP [1 ]
Wendt, T [1 ]
机构：
[1] FSU Jena, Klin Strahlentherapie, Jena, Germany
来源：
STRAHLENTHERAPIE UND ONKOLOGIE | 2004年 / 180卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：57 / 57
页数：1
相关论文
共 50 条
  • [11] Comorbidity and KPS are independent prognostic factors in stage I non-small-cell lung cancer
    Firat, S
    Bousamra, M
    Gore, E
    Byhardt, RW
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2002, 52 (04): : 1047 - 1057
  • [12] PPM1H is an independent prognostic biomarker of non-small-cell lung cancer
    Zhang, Wen-Qi
    Gao, Jian-Nan
    Chen, Xiang-Lei
    Yang, Xi-Feng
    NEOPLASMA, 2021, 68 (05) : 917 - +
  • [13] Prognostic gene signatures for non-small-cell lung cancer
    Boutros, Paul C.
    Lau, Suzanne K.
    Pintilie, Melania
    Liu, Ni
    Shepherd, Frances A.
    Der, Sandy D.
    Tsao, Ming-Sound
    Penn, Linda Z.
    Jurisica, Igor
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2009, 106 (08) : 2824 - 2828
  • [14] LMO4 is a prognostic marker involved in cell migration and invasion in non-small-cell lung cancer
    Wang, Wenjun
    Wu, Sipei
    Guo, Minzhang
    He, Jianxing
    JOURNAL OF THORACIC DISEASE, 2016, 8 (12) : 3682 - 3690
  • [15] High-level expression of Rad51 is an independent prognostic marker of survival in non-small-cell lung cancer patients
    Qiao, GB
    Wu, YL
    Yang, XN
    Zhong, WZ
    Xie, D
    Guan, XY
    Fischer, D
    Kolberg, HC
    Kruger, S
    Stuerzbecher, HW
    BRITISH JOURNAL OF CANCER, 2005, 93 (01) : 137 - 143
  • [16] High-level expression of Rad51 is an independent prognostic marker of survival in non-small-cell lung cancer patients
    G-B Qiao
    Y-L Wu
    X-N Yang
    W-Z Zhong
    D Xie
    X-Y Guan
    D Fischer
    H-C Kolberg
    S Kruger
    H-W Stuerzbecher
    British Journal of Cancer, 2005, 93 : 137 - 143
  • [17] Prognostic Impact of a Novel Tumor Marker and Inflammation Index for Patients With Non-small-cell Lung Cancer
    Tomita, Masaki
    Maeda, Ryo
    Ayabe, Takanori
    Nakamura, Kunihide
    ANTICANCER RESEARCH, 2020, 40 (07) : 4023 - 4027
  • [18] miR-34a as a prognostic marker of relapse in surgically resected non-small-cell lung cancer
    Gallardo, Elena
    Navarro, Alfons
    Vinolas, Nuria
    Marrades, Ramon M.
    Diaz, Tania
    Gel, Bernat
    Quera, Angels
    Bandres, Eva
    Garcia-Foncillas, Jesus
    Ramirez, Jose
    Monzo, Mariano
    CARCINOGENESIS, 2009, 30 (11) : 1903 - 1909
  • [19] PTPRF Expression as a Potential Prognostic/Predictive Marker for Treatment with Erlotinib in Non-Small-Cell Lung Cancer
    Soulieres, Denis
    Hirsch, Fred R.
    Shepherd, Frances A.
    Bordogna, Walter
    Delmar, Paul
    Shames, David S.
    Klughammer, Barbara
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : 1364 - 1369
  • [20] piRNA-651 as a prognostic marker in surgically resected non-small-cell lung cancer.
    Vinolas, Nuria
    Aya, Francisco
    Navarro, Alfons
    Marrades, Ramon M.
    Cordeiro, Anna
    Fernandez, Aranzazu
    Chic, Nuria
    Gimferrer, Josep M.
    Ramirez, Jose
    Molins, Laureano
    Monzo, Mariano
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
12345